학술논문

Gemcitabine/Clofarabine/Busulfan: A New Myeloablative Reduced-Toxicity Conditioning Regimen with High Activity for Allogeneic Stem-Cell Transplant (alloSCT) in Aggressive Lymphomas
Document Type
Abstract
Source
In Blood 8 December 2017 130 Supplement 1:1966-1966
Subject
Language
ISSN
0006-4971